Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GI98-1

Phase I/II Study of Gemcitabine and Docetaxel in Combination for Unresectable or Metastatic Pancreatic Cancer – GI98-1

Abstracts/Posters/Presentations:

  • Bryan P Schneider, Kristen N Ganjoo, Lawrence H Einhorn, Joel Picus, Farid Fata, Patrick J Loehrer, Cindy Stoner. Phase II study of gemcitabine and docetaxel in combination for advanced pancreatic cancer: Hoosier Oncology Group GI98-1. Accepted as a poster presentation with discussion for ASCO annual meeting May 18-21, 2002, Orlando, FL.

Manuscripts/Articles:

  • Ganjoo Kristen N., Gordon Michael S., Sandler Alan B., Warner Ruth E., Fife Karen, Poirier Shelley, Seshadri Roopa, Loehrer Patrick J. A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer: A Hoosier Oncology Group Study GI98-1. Oncology 2002;62:299-304.